Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
2.570
-0.110 (-4.10%)
At close: Apr 28, 2026, 4:00 PM EDT
2.608
+0.038 (1.46%)
After-hours: Apr 28, 2026, 6:32 PM EDT
Replimune Group Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Replimune Group stock have an average target of 5.67, with a low estimate of 2.00 and a high estimate of 14. The average target predicts an increase of 120.62% from the current stock price of 2.57.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Replimune Group stock from 9 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
| Buy | 4 | 4 | 4 | 4 | 4 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 13, 2026 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $11 → $2 | Buy → Hold | Downgrades | $11 → $2 | -22.18% | Apr 13, 2026 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Apr 13, 2026 |
| Wedbush | Wedbush | Buy → Hold Downgrades $19 → $2 | Buy → Hold | Downgrades | $19 → $2 | -22.18% | Apr 13, 2026 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $13 → $2 | Strong Buy → Hold | Downgrades | $13 → $2 | -22.18% | Apr 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
33.07M
EPS This Year
-3.44
from -3.07
EPS Next Year
-2.36
from -3.44
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | 173.4M | ||||||
| Avg | n/a | 33.1M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -3.33 | -1.68 | ||||||
| Avg | -3.44 | -2.36 | ||||||
| Low | -3.44 | -2.87 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.